Lipopolysaccharide Causes Acquired CFTR Dysfunction in Murine Nasal Airways
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1143 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, 2025. Written by Jessica W Grayson and 5 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA. Major MEDLINE topics: Lipopolysaccharides, Cystic Fibrosis Transmembrane Conductance Regulator, Nasal Mucosa, Cystic Fibrosis. Cited 1 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute, NCCIH NIH HHS, Cystic Fibrosis Foundation Research.
Abstract (original language)
Objective
Cystic fibrosis (CF) is a clinical entity defined by aberrant chloride (Cl − ) ion transport causing downstream effects on mucociliary clearance (MCC) in sinonasal epithelia. Inducible deficiencies in transepithelial Cl − transport via CF transmembrane conductance regulator (CFTR) has been theorized to be a driving process in recalcitrant chronic rhinosinusitis (CRS) in patients without CF. We have previously identified that brief exposures to bacterial lipopolysaccharide (LPS) in mammalian cells induces an acquired dysfunction of CFTR in vitro and in vivo. The objective of the current study is to evaluate whether LPS generates a model of acquired CFTR dysfunction murine nasal airways. Study Design Basic science.
Setting
Laboratory.
Methods
CFTR +/+ murine nasal airways were irrigated with 2 µg/mL LPS or control vehicle twice daily for 1 week and transepithelial Cl − transport assessed with the nasal potential difference (NPD) assay. Histopathologic evaluation included the number of lymphoid aggregates, as well as the epithelial and subepithelial heights.
Results
Transepithelial Cl − secretion by NPD was markedly reduced in mice exposed to LPS (in mV, −0.14 ± 7.7 vs control, −6.98 ± 7.15, P < .05), while amiloride‐sensitive voltage was preserved (6.38 ± 5.09 vs control, 7.36 ± 2.87, P = .99). Histopathology demonstrated significantly higher lymphoid aggregates per high‐power field (2.3 ± 0.9 vs 1.1 ± 0.7, control, P < .01) and increased epithelial height (in µm, 40.88 ± 13.9 vs control, 25.32 ± 6.26, P < .05).
Conclusion
Twice daily irrigation with LPS in murine nasal airways over 1 week led to acquired defects in transepithelial Cl − transport. This animal model provides an excellent means to test the contributions of acquired CFTR dysfunction to CRS and test CFTR correctors and potentiators that might improve MCC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
- Departments of Surgery and Veterans Affairs Birmingham, Division of Otolaryngology, Birmingham, Alabama, USA.
- Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama Birmingham, Birmingham, Alabama, USA.
ORCID profiles: Bradford A Woodworth
Funding
- National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute
- NCCIH NIH HHS
- Cystic Fibrosis Foundation Research
- NIH/National Institutes of Allergy and Infectious disease
Cite
APA
Grayson, J. W., Norwood, T. G., Zhang, S., Skinner, D., Cho, D. Y., & Woodworth, B. A. (2025). Lipopolysaccharide Causes Acquired CFTR Dysfunction in Murine Nasal Airways. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1143
Vancouver
Grayson JW, Norwood TG, Zhang S, Skinner D, Cho DY, Woodworth BA. Lipopolysaccharide Causes Acquired CFTR Dysfunction in Murine Nasal Airways. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1143
BibTeX
@article{Grayson2025,
author = {Grayson, Jessica W and Norwood, T Graham and Zhang, Shaoyan and Skinner, Daniel and Cho, Do-Yeon and Woodworth, Bradford A},
title = {Lipopolysaccharide Causes Acquired CFTR Dysfunction in Murine Nasal Airways},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1143}
}
EUVIMED